Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 5
1964 10
1965 2
1966 18
1967 17
1968 26
1969 28
1970 14
1971 25
1972 40
1973 34
1974 56
1975 25
1976 41
1977 24
1978 21
1979 31
1980 49
1981 42
1982 47
1983 55
1984 46
1985 63
1986 31
1987 53
1988 50
1989 104
1990 113
1991 96
1992 78
1993 92
1994 75
1995 91
1996 114
1997 99
1998 114
1999 96
2000 85
2001 143
2002 107
2003 137
2004 132
2005 159
2006 115
2007 136
2008 176
2009 157
2010 153
2011 172
2012 189
2013 186
2014 203
2015 225
2016 259
2017 253
2018 241
2019 224
2020 232
2021 234
2022 218
2023 215
2024 72

Text availability

Article attribute

Article type

Publication date

Search Results

5,913 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Classification, Screening and Diagnosis for Thalassemia.
Viprakasit V, Ekwattanakit S. Viprakasit V, et al. Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006. Hematol Oncol Clin North Am. 2018. PMID: 29458726 Review.
In addition to the previous terminology of "thalassemia major" or "thalassemia intermedia," this classification has embraced all other forms of thalassemia syndromes such as alpha-thalassemia, hemoglobin E/beta-thalassemia and combined alpha- and beta-thalassemias. Definitive dia …
In addition to the previous terminology of "thalassemia major" or "thalassemia intermedia," this classification has embraced all other forms …
Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease.
Leonard A, Tisdale JF, Bonner M. Leonard A, et al. Hematol Oncol Clin North Am. 2022 Aug;36(4):769-795. doi: 10.1016/j.hoc.2022.03.008. Epub 2022 Jun 27. Hematol Oncol Clin North Am. 2022. PMID: 35773052 Review.
Autologous gene therapy has the potential to offer a universal cure that overcomes many limitations of allogeneic HSCT including the lack of available donors, graft-vs-host disease, and graft rejection. Significant progress in gene therapy for the hemoglobinopathies has be …
Autologous gene therapy has the potential to offer a universal cure that overcomes many limitations of allogeneic HSCT including the lack of …
Sickle cell disease: a review for the internist.
Pinto VM, Balocco M, Quintino S, Forni GL. Pinto VM, et al. Intern Emerg Med. 2019 Oct;14(7):1051-1064. doi: 10.1007/s11739-019-02160-x. Epub 2019 Aug 5. Intern Emerg Med. 2019. PMID: 31385153 Review.
Sickle cell disease (SCD) is the most important hemoglobinopathy worldwide in terms of frequency and social impact, recently recognized as a global public health problem by the World Health Organization. ...
Sickle cell disease (SCD) is the most important hemoglobinopathy worldwide in terms of frequency and social impact, recently recogniz …
Prevalence and Management of β-Thalassemia in India.
Yadav SS, Panchal P, Menon KC. Yadav SS, et al. Hemoglobin. 2022 Jan;46(1):27-32. doi: 10.1080/03630269.2021.2001346. Epub 2022 Feb 7. Hemoglobin. 2022. PMID: 35129043 Review.
India bears a huge burden of hemoglobinopathies, and the most prevalent is thalassemia. The different types of thalassemia include minor, major and intermedia, based on the alpha/beta-globin chain inequality. ...In Eastern India, tribal populations had a higher prevalence …
India bears a huge burden of hemoglobinopathies, and the most prevalent is thalassemia. The different types of thalassemia include mi …
Laboratory Approach to Hemolytic Anemia.
Jamwal M, Sharma P, Das R. Jamwal M, et al. Indian J Pediatr. 2020 Jan;87(1):66-74. doi: 10.1007/s12098-019-03119-8. Epub 2019 Dec 10. Indian J Pediatr. 2020. PMID: 31823208 Review.
Sanger sequencing along with conventional testing is the most efficient way to diagnose the underlying genetic causes, especially in thalassemias/hemoglobinopathies, if required. However, hemolytic anemias being highly heterogeneous disorders, next-generation sequencing-ba …
Sanger sequencing along with conventional testing is the most efficient way to diagnose the underlying genetic causes, especially in thalass …
The hemoglobinopathies, molecular disease mechanisms and diagnostics.
Harteveld CL, Achour A, Arkesteijn SJG, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S, Schaap R, Vijfhuizen L, El Idrissi H, Koopmann TT. Harteveld CL, et al. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):28-36. doi: 10.1111/ijlh.13885. Int J Lab Hematol. 2022. PMID: 36074711 Free PMC article. Review.
Hemoglobinopathies are the most common monogenic disorders in the world with an ever increasing global disease burden each year. As most hemoglobinopathies show recessive inheritance carriers are usually clinically silent. ...
Hemoglobinopathies are the most common monogenic disorders in the world with an ever increasing global disease burden each year. As m
Gene Therapy for beta-Hemoglobinopathies: From Discovery to Clinical Trials.
Segura EER, Ayoub PG, Hart KL, Kohn DB. Segura EER, et al. Viruses. 2023 Mar 9;15(3):713. doi: 10.3390/v15030713. Viruses. 2023. PMID: 36992422 Free PMC article. Review.
Due to the advanced understanding of the beta-globin gene cluster, the first diseases considered for autologous HSCT-GT were two prevalent beta-hemoglobinopathies: sickle cell disease and beta-thalassemia, both affecting functional beta-globin chains and leading to substan …
Due to the advanced understanding of the beta-globin gene cluster, the first diseases considered for autologous HSCT-GT were two prevalent b …
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease.
Ferraresi M, Panzieri DL, Leoni S, Cappellini MD, Kattamis A, Motta I. Ferraresi M, et al. Eur J Pediatr. 2023 Jun;182(6):2509-2519. doi: 10.1007/s00431-023-04900-w. Epub 2023 Mar 31. Eur J Pediatr. 2023. PMID: 36997768 Free PMC article. Review.
Hemoglobinopathies, including thalassemias and sickle cell disease, are the most common monogenic diseases worldwide, with estimated annual births of more than 330,000 affected infants. ...
Hemoglobinopathies, including thalassemias and sickle cell disease, are the most common monogenic diseases worldwide, with estimated
Thalassemic hemoglobinopathies.
Steinberg MH, Adams JG. Steinberg MH, et al. Am J Pathol. 1983 Dec;113(3):396-409. Am J Pathol. 1983. PMID: 6359893 Free PMC article. Review.
Hemoglobinopathies are due to changes in the normal amino acid sequence of globin. ...It is now apparent that a single globin gene can have coding region mutations which simultaneously produce a structural defect (hemoglobinopathy) and a biosynthetic defect (thalass
Hemoglobinopathies are due to changes in the normal amino acid sequence of globin. ...It is now apparent that a single globin gene ca
5,913 results